INO · Forms 3, 4, 5
Insider trades at INOVIO PHARMACEUTICALS, INC.
No open-market insider buys or sells at INOVIO PHARMACEUTICALS, INC. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for INOVIO PHARMACEUTICALS, INC. (INO) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for INOVIO PHARMACEUTICALS, INC. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Wendy L Yarno | Director | Options or other derivatives | Form 4 | ||||
| Jay Shepard | Director | Options or other derivatives | Form 4 | ||||
| Ann Calby Miller | Director | Options or other derivatives | Form 4 | ||||
| David B. Weiner | Director | Options or other derivatives | Form 4 | ||||
| Lota S. Zoth | Director | Options or other derivatives | Form 4 | ||||
| Roger D Dansey | Director | Options or other derivatives | Form 4 | ||||
| Simon X Benito | Director | Options or other derivatives | Form 4 | ||||
| Laurent Humeau | Chief Scientific Officer | Option exercise | 6,027 | Form 4 | |||
| Laurent Humeau | Chief Scientific Officer | Tax withholding | 2,163 | $1.23 | $3K | Form 4 | |
| Michael John Sumner | Chief Medical Officer | Option exercise | 9,450 | Form 4 | |||
| Michael John Sumner | Chief Medical Officer | Tax withholding | 2,693 | $1.23 | $3K | Form 4 | |
| Peter Kies | CFO | Option exercise | 8,700 | Form 4 | |||
| Peter Kies | CFO | Tax withholding | 4,688 | $1.23 | $6K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.